Datamonitor’s Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country. .
* Includes a five-year forecast of the industry
Highlights
The BRIC Pharmaceuticals market grew by 14.9% between 2005 and 2009to reach a value of $54.8 billion.
In 2014, the market is forecast to have a value of $87.6 billion, an increase of 9.8% from 2009.
China was the fastest growing country with a CAGR of 19.9% over the 2005–09 period.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant annual average exchange rates.
CHAPTER 1 INTRODUCTION 12
1.1 What is this report about? 12
1.2 Who is the target reader? 12
1.3 How to use this report 12
1.4 Definitions 12
CHAPTER 2 BRIC PHARMACEUTICALS INDUSTRY OUTLOOK 13
CHAPTER 3 PHARMACEUTICALS IN BRAZIL 16
3.1 Market Overview 16
3.2 Market Value 17
3.3 Market Segmentation I 18
3.4 Market Segmentation II 19
3.5 Market Share 20
3.6 Five Forces Analysis 21
3.7 Leading Companies 29
3.8 Market Forecasts 37
3.9 Macroeconomic Indicators 38
CHAPTER 4 PHARMACEUTICALS IN RUSSIA 40
4.1 Market Overview 40
4.2 Market Value 41
4.3 Market Segmentation I 42
4.4 Market Segmentation II 43
4.5 Market Share 44
4.6 Five Forces Analysis 45
4.7 Leading Companies 53
4.8 Market Forecasts 61
4.9 Macroeconomic Indicators 62
CHAPTER 5 PHARMACEUTICALS IN INDIA 64
5.1 Market Overview 64
5.2 Market Value 65
5.3 Market Segmentation I 66
5.4 Market Segmentation II 67
5.5 Market Share 68
5.6 Five Forces Analysis 69
5.7 Leading Companies 77
5.8 Market Forecasts 88
5.9 Macroeconomic Indicators 89
CHAPTER 6 PHARMACEUTICALS IN CHINA 91
6.1 Market Overview 91
6.2 Market Value 92
6.3 Market Segmentation I 93
6.4 Market Segmentation II 94
6.5 Market Share 95
6.6 Five Forces Analysis 96
6.7 Leading Companies 103
6.8 Market Forecasts 110
6.9 Macroeconomic Indicators 111
CHAPTER 7 APPENDIX 113
7.1 Data Research Methodology 113
LIST OF TABLES
Table 1: Pharmaceuticals industry, BRIC, Revenue ($bn) 2005–14 13
Table 2: Pharmaceuticals industry, BRIC, Revenue ($bn) 2005–09 14
Table 3: Pharmaceuticals industry, BRIC, Revenue ($bn) 2009–14 15
Table 4: Brazil Pharmaceuticals Market Value: $ billion, 2005-2009 17
Table 5: Brazil Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 18
Table 6: Brazil Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 19
Table 7: Brazil Pharmaceuticals Market Share: % Share, by Value, 2009 20
Table 8: Key Facts: Novartis AG 29
Table 9: Key Financials: Novartis AG 30
Table 10: Key Facts: GlaxoSmithKline Plc 32
Table 11: Key Financials: GlaxoSmithKline Plc 34
Table 12: Key Facts: EMS Sigma Pharma 36
Table 13: Brazil Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 37
Table 14: Brazil Size of Population (million) , 2005-2009 38
Table 15: Brazil GDP (Current Prices, $ billion), 2005-2009 38
Table 16: Brazil Inflation, 2005-2009 38
Table 17: Brazil Exchange Rate, 2005-2009 39
Table 18: Russia Pharmaceuticals Market Value: $ billion, 2005-2009 41
Table 19: Russia Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 42
Table 20: Russia Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 43
Table 21: Russia Pharmaceuticals Market Share: % Share, by Value, 2009 44
Table 22: Key Facts: Novartis AG 53
Table 23: Key Financials: Novartis AG 55
Table 24: Key Facts: Ranbaxy 56
Table 25: Key Financials: Ranbaxy 57
Table 26: Key Facts: Pharmstandard 58
Table 27: Key Facts: Chemie/Menarini 59
Table 28: Russia Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 61
Table 29: Russia Size of Population (million) , 2005-2009 62
Table 30: Russia GDP (Current Prices, $ billion), 2005-2009 62
Table 31: Russia Inflation, 2005-2009 62
Table 32: Russia Exchange Rate, 2005-2009 63
Table 33: India Pharmaceuticals Market Value: $ billion, 2005-2009 65
Table 34: India Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 66
Table 35: India Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 67
Table 36: India Pharmaceuticals Market Share: % Share, by Value, 2009 68
Table 37: Key Facts: Cipla Ltd 77
Table 38: Key Financials: Cipla Ltd 78
Table 39: Key Facts: GlaxoSmithKline Plc 79
Table 40: Key Financials: GlaxoSmithKline Plc 81
Table 41: Key Facts: Ranbaxy Laboratories 83
Table 42: Key Financials: Ranbaxy Laboratories 84
Table 43: Key Facts: Piramal Healthcare (PHL) 85
Table 44: Key Financials: Piramal Healthcare (PHL) 87
Table 45: India Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 88
Table 46: India Size of Population (million) , 2005-2009 89
Table 47: India GDP (Current Prices, $ billion), 2005-2009 89
Table 48: India Inflation, 2005-2009 89
Table 49: India Exchange Rate, 2005-2009 90
Table 50: China Pharmaceuticals Market Value: $ billion, 2005-2009 92
Table 51: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 93
Table 52: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 94
Table 53: China Pharmaceuticals Market Share: % Share, by Value, 2009 95
Table 54: Key Facts: Jiangsu Yangtze River Pharmaceutical Group 103
Table 57: Key Facts: Pfizer 107
Table 58: Key Financials: Pfizer 108
Table 59: China Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 110
Table 60: China Size of Population (million) , 2005-2009 111
Table 61: China GDP (Current Prices, $ billion), 2005-2009 111
Table 62: China Inflation, 2005-2009 111
Table 63: China Exchange Rate, 2005-2009 112
LIST OF FIGURES
Figure 1: Pharmaceuticals industry, BRIC, Revenue ($bn) 2005–14 13
Figure 2: Pharmaceuticals industry, BRIC, Revenue ($bn) 2005–09 14
Figure 3: Pharmaceuticals industry, BRIC, Revenue ($bn) 2009–14 15
Figure 4: Brazil Pharmaceuticals Market Value: $ billion, 2005-2009 17
Figure 5: Brazil Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 18
Figure 6: Brazil Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 19
Figure 7: Brazil Pharmaceuticals Market Share: % Share, by Value, 2009 20
Figure 8: Forces Driving Competition in the Pharmaceuticals Market in Brazil, 2009 21
Figure 9: Drivers of Buyer Power in the Pharmaceuticals Market in Brazil, 2009 23
Figure 10: Drivers of Supplier Power in the Pharmaceuticals Market in Brazil, 2009 24
Figure 11: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Brazil, 2009 26
Figure 12: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Brazil, 2009 27
Figure 13: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Brazil, 2009 28
Figure 14: Revenues & Profitability: Novartis AG 31
Figure 15: Revenues & Profitability: GlaxoSmithKline Plc 35
Figure 16: Brazil Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 37
Figure 17: Russia Pharmaceuticals Market Value: $ billion, 2005-2009 41
Figure 18: Russia Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 42
Figure 19: Russia Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 43
Figure 20: Russia Pharmaceuticals Market Share: % Share, by Value, 2009 44
Figure 21: Forces Driving Competition in the Pharmaceuticals Market in Russia, 2009 45
Figure 22: Drivers of Buyer Power in the Pharmaceuticals Market in Russia, 2009 47
Figure 23: Drivers of Supplier Power in the Pharmaceuticals Market in Russia, 2009 49
Figure 24: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Russia, 2009 50
Figure 25: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Russia, 2009 51
Figure 26: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Russia, 2009 52
Figure 27: Revenues & Profitability: Novartis AG 55
Figure 28: Revenues & Profitability: Ranbaxy 57
Figure 29: Russia Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 61
Figure 30: India Pharmaceuticals Market Value: $ billion, 2005-2009 65
Figure 31: India Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 66
Figure 32: India Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 67
Figure 33: India Pharmaceuticals Market Share: % Share, by Value, 2009 68
Figure 34: Forces Driving Competition in the Pharmaceuticals Market in India, 2009 69
Figure 35: Drivers of Buyer Power in the Pharmaceuticals Market in India, 2009 71
Figure 36: Drivers of Supplier Power in the Pharmaceuticals Market in India, 2009 72
Figure 37: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in India, 2009 73
Figure 38: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in India, 2009 75
Figure 39: Drivers of Degree of Rivalry in the Pharmaceuticals Market in India, 2009 76
Figure 42: Revenues & Profitability: Ranbaxy Laboratories 84
Figure 44: India Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 88
Figure 45: China Pharmaceuticals Market Value: $ billion, 2005-2009 92
Figure 46: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 93
Figure 47: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 94
Figure 48: China Pharmaceuticals Market Share: % Share, by Value, 2009 95
Figure 49: Forces Driving Competition in the Pharmaceuticals Market in China, 2009 96
Figure 50: Drivers of Buyer Power in the Pharmaceuticals Market in China, 2009 98
Figure 51: Drivers of Supplier Power in the Pharmaceuticals Market in China, 2009 99
Figure 52: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in China, 2009 100
Figure 53: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in China, 2009 101
Figure 54: Drivers of Degree of Rivalry in the Pharmaceuticals Market in China, 2009 102
Figure 56: Revenues & Profitability: Pfizer 109
Figure 57: China Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 110
Other selected research from the 'Brazil' category:
Emerging Clinical Trial Locations -Latin America: Market dynamics and the changing healthcare and regulatory environment
McEvoy and Farmer's Complete Guide to IVD Distribution in Brazil
Other selected research from the 'China' category:
Chinese Pharmaceutical Market 2010-2025
Our new report will show you how the Chinese pharma market will develop from 2010. You can identify where the greatest opportunities will lie... Learn More
Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
Other selected research from the 'India' category:
Opportunities in Indian Healthcare Sector
Indian Biotechnology Market Outlook (2006)
Other selected research from the 'Russia' category:
OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide
Russian Pharma Sector Analysis